Mushrooms Inc (MSRM) Ratios
Mushrooms Inc Ratios
MSRM's free cash flow for Q2 2026 was $-180.00. For the 2026 fiscal year, MSRM's free cash flow was increased by $0.00 and operating cash flow was $-178.00. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.16 | 0.23 | 0.17 | 0.12 | 0.18 |
| Quick Ratio | 0.00 | 0.23 | 0.11 | 0.09 | 0.18 |
| Cash Ratio | 0.00 | 0.01 | 0.02 | 0.00 | 0.06 |
| Solvency Ratio | -0.30 | -0.14 | -1.48 | -3.86 | -3.09 |
| Operating Cash Flow Ratio | 0.03 | 0.00 | -0.35 | -0.01 | -0.16 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | -19.09 | -0.74 | -4.74 |
| Net Current Asset Value | $ -68.76K | $ -52.76K | $ -169.34K | $ -160.28K | $ -110.94K |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 1.93 | 1.83 | 0.87 | 0.12 | 0.18 |
| Debt-to-Equity Ratio | -0.39 | -0.62 | -0.17 | -0.02 | -0.04 |
| Debt-to-Capital Ratio | -0.64 | -1.60 | -0.20 | -0.02 | -0.04 |
| Long-Term Debt-to-Capital Ratio | -0.64 | -1.20 | -0.18 | 0.00 | 0.00 |
| Financial Leverage Ratio | -0.20 | -0.34 | -0.19 | -0.17 | -0.23 |
| Debt Service Coverage Ratio | -48.63 | -2.63 | -90.95 | -217.88 | -92.72 |
| Interest Coverage Ratio | -53.34 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 0.03 | 0.07 | 0.02 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Debt to EBITDA | -1.10 | -3.29 | -0.09 | -0.00 | 0.01 |
| Profitability Margins | |||||
| Gross Profit Margin | -43.88% | -121.45% | 0.00% | 0.00% | 100.00% |
| EBIT Margin | -1038.26% | -1086.41% | 0.00% | 0.00% | -12501.83% |
| EBITDA Margin | -946.60% | -868.44% | 0.00% | 0.00% | -8001.96% |
| Operating Profit Margin | -1038.26% | -1051.69% | 0.00% | 0.00% | -12105.95% |
| Pretax Profit Margin | -1057.72% | -1086.93% | 0.00% | 0.00% | -12501.83% |
| Net Profit Margin | -1057.72% | -1086.93% | 0.00% | 0.00% | -12501.83% |
| Continuous Operations Profit Margin | -1057.72% | -1086.93% | 0.00% | 0.00% | -12501.83% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 101.87% | 103.35% | 100.00% | 100.00% | 103.27% |
| Return on Assets (ROA) | -194.39% | -69.08% | -917.42% | -2710.41% | -2628.88% |
| Return on Equity (ROE) | 39.36% | 23.20% | 177.40% | 451.23% | 592.38% |
| Return on Capital Employed (ROCE) | 63.38% | 49.33% | 208.61% | 451.23% | 573.63% |
| Return on Invested Capital (ROIC) | 63.38% | 58.35% | 213.46% | 460.76% | 598.08% |
| Return on Tangible Assets | -304.95% | -124.95% | -986.35% | -3226.27% | -2628.88% |
| Earnings Yield | -2.61% | -2.57% | -21.06% | -57.00% | -3.71% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.05 |
| Payables Turnover | 0.37 | 0.65 | 2.06 | 0.02 | 0.00 |
| Inventory Turnover | 0.42 | 0.00 | 0.27 | 0.29 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.18 | 0.06 | 0.00 | 0.00 | 0.21 |
| Working Capital Turnover Ratio | -0.07 | -0.01 | 0.00 | 0.00 | -0.06 |
| Cash Conversion Cycle | -115.03 | -557.26 | 1156.76 | -17034.30 | 8025.76 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 8025.76 |
| Days of Inventory Outstanding | 868.66 | 0.00 | 1333.84 | 1253.65 | 0.00 |
| Days of Payables Outstanding | 983.69 | 557.26 | 177.08 | 18287.95 | 0.00 |
| Operating Cycle | 868.66 | 0.00 | 1333.84 | 1253.65 | 8025.76 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.00 | 0.00 | -0.00 | -0.00 | -0.00 |
| Free Cash Flow Per Share | 0.00 | 0.00 | -0.00 | -0.00 | -0.00 |
| Dividend Paid and CapEx Coverage Ratio | 304.11 | 0.00 | -61.74 | -0.43 | 0.00 |
| Capital Expenditure Coverage Ratio | 304.11 | 0.00 | -61.74 | -0.43 | 0.00 |
| Operating Cash Flow Coverage Ratio | 0.06 | 0.00 | -2.18 | -0.74 | -4.74 |
| Operating Cash Flow to Sales Ratio | 0.59 | 0.00 | 0.00 | 0.00 | -4.09 |
| Free Cash Flow Yield | 0.15% | 0.00% | -4.45% | -0.64% | -0.12% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -38.28 | -35.00 | -4.75 | -1.75 | -26.97 |
| Price-to-Sales (P/S) Ratio | 404.92 | 422.96 | 0.00 | 0.00 | 3371.91 |
| Price-to-Book (P/B) Ratio | -15.07 | -9.03 | -8.42 | -7.92 | -159.77 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 684.64 | 0.00 | -22.48 | -156.05 | -823.71 |
| Price-to-Operating Cash Flow Ratio | 687.07 | 0.00 | -22.85 | -519.50 | -823.71 |
| Price-to-Earnings Growth (PEG) Ratio | 0.38 | 0.36 | 0.07 | 0.04 | 0.33 |
| Enterprise Value Multiple | -43.88 | -51.99 | -4.88 | -1.76 | -42.13 |
| Enterprise Value | 990.23K | 442.01K | 1.43M | 1.24M | 17.72M |
| EV to EBITDA | -43.88 | -51.99 | -4.88 | -1.76 | -42.13 |
| EV to Sales | 415.37 | 451.49 | 0.00 | 0.00 | 3371.16 |
| EV to Free Cash Flow | 702.29 | 0.00 | -22.88 | -156.38 | -823.52 |
| EV to Operating Cash Flow | 704.79 | 0.00 | -23.26 | -520.62 | -823.52 |
| Tangible Book Value Per Share | -0.00 | -0.00 | -0.00 | -0.01 | -0.01 |
| Shareholders’ Equity Per Share | -0.00 | -0.00 | -0.00 | -0.01 | -0.01 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.00 | -0.00 | -0.01 | -0.02 | -0.04 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.02 | 1.00 | 1.00 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.00 | 1.02 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 9.94 | 8.28 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | -0.06 | 0.00 | 0.21 | 0.10 | 0.53 |
Currency in USD
